Antileukemic effect of a synthetic vitamin D-3 analog, HY-11, with low potential to cause hypercalcemia
- Authors
- Yoon, Jin Sun; Kim, Ju Young; Park, Hyun Ki; Kim, Eun Shil; Ahn, Kwang Sung; Yoon, Sung Soo; Ch, Cheon Gyu; Kim, Byoung Kook; Lee, Young Yiul
- Issue Date
- Feb-2008
- Publisher
- PROFESSOR D A SPANDIDOS
- Keywords
- vitamin D3 analog; HY-11; acute myelogenous leukemia; cell line; cell cycle; apoptosis; BALB/c leukemia model
- Citation
- INTERNATIONAL JOURNAL OF ONCOLOGY, v.32, no.2, pp.387 - 396
- Indexed
- SCIE
SCOPUS
- Journal Title
- INTERNATIONAL JOURNAL OF ONCOLOGY
- Volume
- 32
- Number
- 2
- Start Page
- 387
- End Page
- 396
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/179016
- DOI
- 10.3892/ijo.32.2.387
- ISSN
- 1019-6439
- Abstract
- 1 alpha,25-dihydroxyvitaminD(3) [1,25(OH)(2)D-3] is capable of inhibiting the proliferation of acute myelogenous leukemia (AML). However, toxicity of hypercalcemia has limited the use of 1,25(OH)(2)D-3 in clinical trials. We have evaluated 11 synthesized vitamin D-3 analogs for their ability to inhibit clonal growth of HL-60 mycloid leukemic cells. Among the 11 vitamin D-3 analogs, HY-11 (code name) showed the most potent antileukemic activity with 2.5x10(-6) M of IC50, however, it did not affect the cellular growth of normal peripheral blood mononuclear cells until 10(-6) M. Flow cytometric analysis indicated that HY-11 induced the G1 arrest in a dose-dependent manner, which was mediated via inactivation of CDK4 and CDK6 in association with upregulation of CDKI (cyclin-dependent kinase inhibitor), p27 and Rb protein. Induction of apoptosis was mediated via caspase-3 pathway in HY-11-treated HL-60. In addition, HY-11 enhanced the expression of TGF-beta 1, TGF-beta receptor type I and II and vitamin D3 receptor (VDR). VDR expression was increased by TGF-beta 1, suggesting that TGF-beta 1 might be involved in the antiproliferative effect of HY-11 on HL-60 cells by autocrine and paracrine regulation. Serum calcium levels were within normal limit when HY-11 was given intraperitoneally (i.p.) every other day for 5 weeks to BALB/c mice at the doses of 10(-7), 10(-6) and 10(-5) M. HY-11 inhibited the growth of WEHI-3BD(+) mouse leukemic cells in vitro, and syngeneic BALB/c mice that received WEHI-3BD(+) mouse leukemic cells and HY-11 had a significantly longer survival without producing hypercalcemia compared to control group. In summary, HY-11 is a vitamin D-3 analog that inhibited the proliferation of human AML cell line, HL-60, through induction of cell cycle arrest, triggering apoptosis as well as modulation of TGF-beta 1 and its receptors. In particular, HY-11 significantly increased the survival of mice that had myeloid leukemia without producing hypercalcemia.
- Files in This Item
-
- Appears in
Collections - 서울 자연과학대학 > 서울 화학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.